Connection

Perry Molinoff to Kinetics

This is a "connection" page, showing publications Perry Molinoff has written about Kinetics.
Connection Strength

0.621
  1. Regulation of D2 and D3 receptors in transfected cells by agonists and antagonists. Adv Pharmacol. 1998; 42:443-6.
    View in: PubMed
    Score: 0.033
  2. Development of polyclonal anti-D2 dopamine receptor antibodies to fusion proteins: inhibition of D2 receptor-G protein interaction. J Neurochem. 1993 Jun; 60(6):2181-91.
    View in: PubMed
    Score: 0.024
  3. Regulation of the 5-hydroxytryptamine1B receptor in opossum kidney cells after exposure to agonists. Mol Pharmacol. 1992 Sep; 42(3):464-70.
    View in: PubMed
    Score: 0.023
  4. Regulation of dopamine D2 receptors in a novel cell line (SUP1). Mol Pharmacol. 1991 Apr; 39(4):531-9.
    View in: PubMed
    Score: 0.021
  5. Characterization of polyamines having agonist, antagonist, and inverse agonist effects at the polyamine recognition site of the NMDA receptor. Neuron. 1990 Aug; 5(2):199-208.
    View in: PubMed
    Score: 0.020
  6. Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line. Mol Pharmacol. 1990 May; 37(5):622-30.
    View in: PubMed
    Score: 0.019
  7. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM. J Pharmacol Exp Ther. 1989 Jul; 250(1):110-6.
    View in: PubMed
    Score: 0.018
  8. Effect of exercise duration on density and coupling of beta-adrenergic receptors on human mononuclear cells. J Appl Physiol (1985). 1989 Mar; 66(3):1494-500.
    View in: PubMed
    Score: 0.018
  9. Characterization of binding sites for [3H]spiroperidol. Biochem Pharmacol. 1987 Oct 01; 36(19):3255-64.
    View in: PubMed
    Score: 0.016
  10. Distribution and properties of beta-adrenergic receptors in human iris-ciliary body. Invest Ophthalmol Vis Sci. 1987 Mar; 28(3):420-30.
    View in: PubMed
    Score: 0.016
  11. Evaluation of models for analysis of radioligand binding data. Mol Pharmacol. 1987 Jan; 31(1):103-11.
    View in: PubMed
    Score: 0.015
  12. Down regulation of beta adrenergic receptors in S49 lymphoma cells induced by atypical agonists. J Pharmacol Exp Ther. 1986 Dec; 239(3):654-60.
    View in: PubMed
    Score: 0.015
  13. Kinetic analysis of the interactions of agonists and antagonists with beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Oct; 239(1):136-43.
    View in: PubMed
    Score: 0.015
  14. A quantitative method of analyzing the interaction of slightly selective radioligands with multiple receptor subtypes. Mol Pharmacol. 1986 Oct; 30(4):329-37.
    View in: PubMed
    Score: 0.015
  15. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes. J Pharmacol Exp Ther. 1986 Oct; 239(1):117-23.
    View in: PubMed
    Score: 0.015
  16. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade. Mol Pharmacol. 1986 Aug; 30(2):104-11.
    View in: PubMed
    Score: 0.015
  17. Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Jul; 238(1):46-53.
    View in: PubMed
    Score: 0.015
  18. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Apr; 237(1):154-64.
    View in: PubMed
    Score: 0.015
  19. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. II. Agonist binding to soluble beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Apr; 237(1):165-72.
    View in: PubMed
    Score: 0.015
  20. Properties of beta-adrenergic receptors of cultured mammalian cells. Interaction of receptors with a guanine nucleotide-binding protein in membranes prepared from L6 myoblasts and from wild-type and cyc- S49 lymphoma cells. J Biol Chem. 1985 Nov 25; 260(27):14580-8.
    View in: PubMed
    Score: 0.014
  21. Beta 2-adrenergic receptors contribute to catecholamine-stimulated shortening of action potential duration in dog atrial muscle. Proc Natl Acad Sci U S A. 1985 Jul; 82(13):4521-5.
    View in: PubMed
    Score: 0.014
  22. Assay of dopamine receptors with [alpha-3H]flupenthixol. J Pharmacol Exp Ther. 1985 Jan; 232(1):57-61.
    View in: PubMed
    Score: 0.013
  23. Desensitization of beta-adrenergic receptor-coupled adenylate cyclase activity. Differences following exposure of cells to two full agonists. Biochem Pharmacol. 1984 Nov 15; 33(22):3579-84.
    View in: PubMed
    Score: 0.013
  24. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists. Mol Pharmacol. 1984 Mar; 25(2):209-18.
    View in: PubMed
    Score: 0.013
  25. Multiple sites of action of ethanol on adenylate cyclase. J Pharmacol Exp Ther. 1983 Dec; 227(3):551-6.
    View in: PubMed
    Score: 0.012
  26. Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum. Proc Natl Acad Sci U S A. 1982 Dec; 79(23):7561-5.
    View in: PubMed
    Score: 0.012
  27. Selective increases in the density of cerebellar beta-1-adrenergic receptors. Brain Res. 1982 Feb 25; 234(2):474-9.
    View in: PubMed
    Score: 0.011
  28. Effects of magnesium and N-ethylmaleimide on the binding of 3H-hydroxybenzylisoproterenol to beta-adrenergic receptors. J Biol Chem. 1982 Jan 25; 257(2):804-10.
    View in: PubMed
    Score: 0.011
  29. Quantitative analysis of drug-receptor interactions: II. Determination of the properties of receptor subtypes. Life Sci. 1981 Aug 03; 29(5):427-43.
    View in: PubMed
    Score: 0.011
  30. Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties. Life Sci. 1981 Jul 27; 29(4):313-30.
    View in: PubMed
    Score: 0.011
  31. Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior. Brain Res. 1981 May 04; 211(2):315-27.
    View in: PubMed
    Score: 0.010
  32. Binding of [3H]amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat striatal membranes. Effects of purine nucleotides and ultraviolet irradiation. Mol Pharmacol. 1981 May; 19(3):372-8.
    View in: PubMed
    Score: 0.010
  33. Interactions of agonists and antagonists with beta-adrenergic receptors. Adv Cyclic Nucleotide Res. 1981; 14:51-67.
    View in: PubMed
    Score: 0.010
  34. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors. Mol Pharmacol. 1980 Nov; 18(3):341-7.
    View in: PubMed
    Score: 0.010
  35. Characterization of radiolabeled agonist binding to beta-adrenergic receptors in mammalian tissues. J Cyclic Nucleotide Res. 1980; 6(3):217-30.
    View in: PubMed
    Score: 0.009
  36. A comparison of the beta-adrenergic receptor of the turkey erythrocyte with mammalian beta1 and beta2 receptors. Mol Pharmacol. 1980 Jan; 17(1):1-7.
    View in: PubMed
    Score: 0.009
  37. Interactions of agonists and antagonists with beta-adrenergic receptors on intact L6 muscle cells. J Cyclic Nucleotide Res. 1980; 6(6):421-35.
    View in: PubMed
    Score: 0.009
  38. Comparison of beta adrenergic receptor subtypes in mammalian tissues. J Pharmacol Exp Ther. 1979 Dec; 211(3):502-8.
    View in: PubMed
    Score: 0.009
  39. Increased membrane acyl chain ordering activates adenylate cyclase. J Biol Chem. 1979 Sep 25; 254(18):9135-41.
    View in: PubMed
    Score: 0.009
  40. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro. Mol Pharmacol. 1979 Jul; 16(1):21-33.
    View in: PubMed
    Score: 0.009
  41. Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol. 1979 Jul; 16(1):34-46.
    View in: PubMed
    Score: 0.009
  42. beta1- and beta2-Adrenergic receptors in rat cerebral cortex are independently regulated. Science. 1979 May 25; 204(4395):866-8.
    View in: PubMed
    Score: 0.009
  43. Dopamine-beta-hydroxylase and the regulation of the noradrenergic neuron. Adv Biochem Psychopharmacol. 1974; 12(0):95-104.
    View in: PubMed
    Score: 0.006
  44. A sensitive enzymatic assay for dopamine- -hydroxylase. J Pharmacol Exp Ther. 1971 Sep; 178(3):425-31.
    View in: PubMed
    Score: 0.005
  45. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Brain Res Dev Brain Res. 1991 Jun 21; 60(2):161-77.
    View in: PubMed
    Score: 0.005
  46. Comparison of 125I-SCH 23982 and [3H]SCH 23390 as ligands for the D-1 dopamine receptor. J Neurochem. 1988 Aug; 51(2):391-7.
    View in: PubMed
    Score: 0.004
  47. The metabolism of gamma-aminobutyric acid (GABA) in the lobster nervous system--glutamic decarboxylase. J Neurochem. 1968 May; 15(5):391-409.
    View in: PubMed
    Score: 0.004
  48. Role of beta-adrenergic receptors in catecholamine-induced desensitization of adenylate cyclase in human astrocytoma cells. J Biol Chem. 1978 Mar 10; 253(5):1472-80.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.